{
    "title": "Experimental cholesterol drugs cut heart risk, but questions remain",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2995815/Experimental-cholesterol-drugs-cut-heart-risk-questions-remain.html",
    "date": "2015-03-15",
    "keywords": [
        "heart",
        "percent",
        "cholesterol",
        "treatment",
        "repatha",
        "drug",
        "risk",
        "march",
        "attack",
        "pcsk9",
        "amgen",
        "death",
        "ldl",
        "gmt",
        "diego",
        "event",
        "group",
        "study",
        "chest",
        "pain",
        "trial",
        "praluent",
        "sanofiregeneron",
        "fda",
        "email",
        "beasleysan",
        "class",
        "meeting",
        "college",
        "cardiology",
        "analysis",
        "year",
        "incs",
        "evolocumab",
        "therapy",
        "standard",
        "statinsamgen",
        "failure",
        "hospitalization",
        "need",
        "procedure",
        "bloodflow",
        "heartside",
        "something",
        "food",
        "administration",
        "program",
        "scott",
        "wasserman",
        "head",
        "safety",
        "side",
        "arm",
        "sanofi",
        "sa",
        "regeneron",
        "placebo",
        "stroke",
        "hospitalizationsome",
        "kind",
        "anthony",
        "director",
        "center",
        "university",
        "california",
        "encouraging",
        "lead",
        "investigator",
        "reduction",
        "eventsthe",
        "injection",
        "protein",
        "bloodstream",
        "lowcost",
        "production",
        "placeboth",
        "approval",
        "cholesterolthe",
        "application",
        "deadline",
        "blood",
        "use",
        "reporting",
        "deena",
        "beasley",
        "editing"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}